Browse by Medical Category
Call for information on hepatitis C trials:
Massachusetts General Hospital Transplant Center patients have access to leading-edge clinical trials and therapies, including immunosuppression withdrawal and new Hepatitis C treatments.
In spite of advances over the last 50 years in anti-rejection medications, the side effects of long-term immunosuppressive therapy remain a major problem for post-transplant patients. Mass General has been a leader in developing protocols to allow transplant patients to live drug-free and without rejection.For more information about immunosuppression withdrawal studies for liver transplant recipients, call 617-726-2631.
Hepatitis C infection can return after liver transplantation, occasionally causing liver damage severe enough to require re-transplantation. The Liver Transplant Program at the Mass General Transplant Center offers the latest FDA-approved anti-viral therapies and participates in clinical trials utilizing promising new agents. For more information about hepatitis C clinical trials, call 617-724-3836.
Back to Top